Overview
Discounted cash flow
Income / accounting-based
Multiples & assets
Scenario
Toolbox
Weighted blend
$56.20
-55.66% vs spot
Sell
Spot price
$126.75
Mkt cap $6.22B
subtle cardAnalyst PT consensus
$140.00
+10.45% vs spot
subtle cardMethods covered
5 / 5
5 in blend
subtle cardFootball field
ACA · fair-value range by method
Method comparison
ACA · fair value by valuation framework
| Method | Category | Fair value | Range | vs spot | Weight | Driver | Conf. |
|---|---|---|---|---|---|---|---|
| Justified P/E | multiple | $5.55 | $4.72 – $6.39 | -95.62% | 30.0% | Fair P/E 1.3 (payout 5%, kₑ 9.3%, g 5.4%) | med |
| P/E · sector | multiple | $84.80 | $74.62 – $94.98 | -33.10% | 60.0% | EPS 4.24 × peer P/E 20.0 | med |
| PEG-anchored | multiple | $21.20 | $18.02 – $24.38 | -83.27% | 5.0% | PEG=1, fwd EPS g 0.9% | med |
| Graham revised | intrinsic | $80.71 | $68.60 – $92.81 | -36.33% | 2.5% | EPS×(8.5+2g)·4.4/Y | low |
| Lynch P/E=g | intrinsic | $22.88 | $19.45 – $26.32 | -81.95% | 2.5% | PE = g (5.4) | low |
Cost-of-capital build-up
CAPM cost of equity, after-tax cost of debt, WACC. Risk-free as of 2026-05-12.
| Risk-free rate (US 10y Treasury)rf | 4.46% |
| Equity beta (1.08)β | × 1.08 |
| Equity risk premiumERP | 4.46% |
| Cost of equity (CAPM)kₑ | 9.26% |
| Pre-tax cost of debtkd | 7.14% |
| Effective tax ratet | 12.1% |
| After-tax cost of debt | 6.28% |
| Equity weight$2.6B | 63.3% |
| Debt weight$1.5B | 36.7% |
| WACC | 8.17% |
Growth assumptions
Blended forward growth used as DCF default; terminal pegged to long-run nominal GDP.
| Analyst forward revenue growthFMP | -8.63% |
| Analyst forward EPS growthFMP | 0.90% |
| Historical 5y revenue CAGRFY | 9.08% |
| Historical 5y EPS CAGRFY | 31.45% |
| Sustainable g (ROE × retention)Δ | 7.57% |
| Blended near-term growth (g₀) | 5.40% |
| Terminal growth (gₗ) | 3.84% |
Sources
- FMP /analyst-estimates— 8 rows(as of 2021-12-30)
- Treasury rates · 10y— 4.46% rf(as of 2026-05-12)
- market_risk_premium · DB— 4.46% ERP(as of 2026-05-13)
- Sector multiple defaults— Industrials (live sector PE unavailable)
- FMP /price-target-consensus— mean $140.00
This page is generated by a quantitative valuation engine for research purposes only and does not constitute investment advice. Methodology follows standard CFA / Damodaran frameworks; assumptions are driven by analyst consensus from Financial Modeling Prep and reported financial statements.